Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia
Clinical trial NCT05776173 · RECRUITING
Trial details
- NCT number
- NCT05776173
- Sponsor
- Shanghai BDgene Co., Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2026-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.